Haleon plc
HLNDrug Manufacturers - Specialty & Generic
£3.18−15.05%As of Oct 29vs prior close
- Market cap
- $37.2B
- P/E (TTM)
- 17.7×
- P/E (FY1)
- 15.1×
- From 52W high
- −16.98%
- EPS (LTM)
- £0.18
- Revenue (LTM)
- £11.2B
- Net margin
- 14.55%
Nomior Score
48
Steady ProfileBottom 45% of the scored universe
Growth40
Quality58
Value51
Momentum—
Resilience48
Growth
+0.53%revenue a year over 3 fiscal years
YE22 £10.9BLTM £11.2B
Connections
Revenue to profitYE25
15% of revenue became net profit, up 2 pts on a year.